Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	$ 1,608,306	$ (7,599)	$ (767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		833,000
Issuance of common stock upon exercise of stock options	83		83
Issuance of common stock under employee stock purchase plan (in shares)		543,000
Issuance of common stock under employee stock purchase plan	1,163		1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		84,000
Issuance of common stock in connection with restricted stock units, net of tax	(119)		(119)
Stock-based compensation	28,105		28,105
Other comprehensive income (loss)	5,220			5,220
Net loss	(130,849)				(130,849)
Ending balance (in shares) at Jun. 30, 2023		251,027,000
Ending balance at Jun. 30, 2023	736,855	$ 25	1,637,538	(2,379)	(898,329)
Beginning balance (in shares) at Mar. 31, 2023		249,609,000
Beginning balance at Mar. 31, 2023	783,826	$ 25	1,622,119	(3,879)	(834,439)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		833,000
Issuance of common stock upon exercise of stock options	$ 83		83
Issuance of common stock under employee stock purchase plan (in shares)	543,000
Issuance of common stock under employee stock purchase plan	$ 1,163
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		42,000
Issuance of common stock in connection with restricted stock units, net of tax	(50)		(50)
Stock-based compensation	14,223		14,223
Other comprehensive income (loss)	1,500			1,500
Net loss	(63,890)				(63,890)
Ending balance (in shares) at Jun. 30, 2023		251,027,000
Ending balance at Jun. 30, 2023	$ 736,855	$ 25	1,637,538	(2,379)	(898,329)
Beginning balance (in shares) at Dec. 31, 2023	253,957,709	253,958,000
Beginning balance at Dec. 31, 2023	$ 654,952	$ 25	1,657,133	(94)	(1,002,112)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	1,245,836	1,246,000
Issuance of common stock upon exercise of stock options	$ 155	$ 1	154
Issuance of common stock under employee stock purchase plan (in shares)		491,000
Issuance of common stock under employee stock purchase plan	810		810
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		253,000
Issuance of common stock in connection with restricted stock units, net of tax	(76)		(76)
Stock-based compensation	17,439		17,439
Other comprehensive income (loss)	(303)			(303)
Net loss	$ (106,476)				(106,476)
Ending balance (in shares) at Jun. 30, 2024	255,948,333	255,948,000
Ending balance at Jun. 30, 2024	$ 566,501	$ 26	1,675,460	(397)	(1,108,588)
Beginning balance (in shares) at Mar. 31, 2024		254,927,000
Beginning balance at Mar. 31, 2024	603,157	$ 25	1,666,315	(404)	(1,062,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		377,000
Issuance of common stock upon exercise of stock options	52	$ 1	51
Issuance of common stock under employee stock purchase plan (in shares)		491,000
Issuance of common stock under employee stock purchase plan	810		810
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		153,000
Stock-based compensation	8,284		8,284
Other comprehensive income (loss)	7			7
Net loss	$ (45,809)				(45,809)
Ending balance (in shares) at Jun. 30, 2024	255,948,333	255,948,000
Ending balance at Jun. 30, 2024	$ 566,501	$ 26	$ 1,675,460	$ (397)	$ (1,108,588)